My Genome. My Health. MyOme.
MyOme (myome.com) earns a Brand Analyzer score of 68 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, MyOme ranks in the 49th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 76/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 68/100, AI Discoverability 48/100, Brand Authority 25/100.
MyOme is a clinical whole genome analysis platform company focused on helping families understand their risk for inherited diseases. The company leverages whole genome sequencing and advanced polygenic modeling to generate comprehensive, clinically actionable reports from a single patient sample. Positioned as a leader in genomic medicine, MyOme offers both proactive and diagnostic genomic tests intended to support personalized lifestyle, prevention, and treatment decisions for individuals and healthcare providers.
| Brand Name | MyOme |
|---|---|
| Domain | myome.com |
| Industry | Healthcare, Technology |
| Main Competitors | Illumina, Invitae, GeneDx, Color Genomics, Myriad Genetics (83/100), 23andMe |
Moz Domain Authority 30/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #3,313,619 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. As a leader in polygenic modeling, MyOme leverages the pow…" (Meta description: 37 words. No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Instagram, GitHub; no detected presence on X (Twitter), Facebook, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
MyOme scores 28/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
MyOme has a weak AI-visibility profile at 28/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (17/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #3,313,619 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 30/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
MyOme's main competitors include Illumina, Invitae, GeneDx, Color Genomics, Myriad Genetics (83/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: MyOme official site
MyOme and Myriad Genetics are competitors in Healthcare. Brand Analyzer scores MyOme at 68/100 and Myriad Genetics at 83/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: MyOme official site
Popular alternatives to MyOme include Illumina, Invitae, GeneDx, Color Genomics, Myriad Genetics (83/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: MyOme official site
MyOme offers a clinical whole genome analysis platform that generates comprehensive, clinically actionable reports from a single patient sample. The company provides both proactive genomic tests - aimed at assessing inherited disease risk before symptoms arise - and diagnostic tests for individuals already seeking answers. These products incorporate whole genome sequencing and polygenic modeling to support personalized health, prevention, and treatment decisions.
Sources: MyOme official site
MyOme is a clinical whole genome analysis platform company. It describes itself as a leader in polygenic modeling and genomic medicine, providing tools and reports that help families understand their risk for inherited diseases. The company combines whole genome sequencing with advanced computational modeling to produce clinically actionable insights intended to support personalized health decisions across a patient's lifetime.
Sources: MyOme official site
MyOme has limited AI-search visibility, scoring 28/100 on Brand Analyzer's AI visibility composite (visibility 17, trust 22, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: MyOme official site
MyOme analyzes whole genome data using advanced polygenic modeling to deliver comprehensive, clinically actionable reports from a single patient sample. The company offers both proactive and diagnostic genomic tests designed to help individuals and healthcare providers make informed decisions about personalized lifestyle choices, disease prevention, and treatment options. Its platform is specifically oriented toward identifying inherited disease risks within families.
Sources: MyOme official site
MyOme scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: MyOme official site
MyOme can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: MyOme official site
According to the known facts, MyOme's target audience includes individuals seeking genomic insights for personalized health decisions and healthcare providers who use genomic data to guide clinical care. The platform is particularly oriented toward families looking to understand their risk for inherited diseases, suggesting use cases in both direct-to-consumer and clinical or provider-mediated settings.
Sources: MyOme official site
MyOme is known for being a leader in polygenic modeling within the clinical genomics space. The company is recognized for its whole genome sequencing-based platform that delivers actionable insights about inherited disease risk. It emphasizes the use of the full genome - rather than targeted panels - to provide a broader and more comprehensive view of a patient's genetic health profile.
Sources: MyOme official site
Ranked closest to MyOme: HealthBridge Financial (68/100), Mustimuhw Information Solutions (MIS) (68/100), My Yoga Ayurveda (68/100), Non-Profit Software Corporation (68/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).